CoreCap Advisors LLC purchased a new stake in IMAX Co. (NYSE:IMAX – Free Report) during the fourth quarter, Holdings Channel reports. The firm purchased 30,212 shares of the company’s stock, valued at approximately $773,000.
A number of other institutional investors and hedge funds have also recently modified their holdings of IMAX. Janney Montgomery Scott LLC raised its position in shares of IMAX by 1.9% in the 4th quarter. Janney Montgomery Scott LLC now owns 29,176 shares of the company’s stock valued at $747,000 after purchasing an additional 533 shares during the last quarter. Blue Trust Inc. grew its holdings in shares of IMAX by 138.5% during the fourth quarter. Blue Trust Inc. now owns 966 shares of the company’s stock valued at $25,000 after buying an additional 561 shares during the last quarter. MetLife Investment Management LLC raised its stake in IMAX by 3.4% in the 4th quarter. MetLife Investment Management LLC now owns 25,918 shares of the company’s stock worth $664,000 after acquiring an additional 848 shares during the last quarter. State of Tennessee Department of Treasury lifted its position in IMAX by 19.8% during the 4th quarter. State of Tennessee Department of Treasury now owns 9,827 shares of the company’s stock worth $252,000 after acquiring an additional 1,627 shares during the period. Finally, Hedges Asset Management LLC grew its stake in IMAX by 3.1% during the 4th quarter. Hedges Asset Management LLC now owns 83,600 shares of the company’s stock valued at $2,140,000 after purchasing an additional 2,500 shares during the last quarter. Hedge funds and other institutional investors own 93.51% of the company’s stock.
IMAX Price Performance
IMAX stock opened at $26.00 on Friday. The stock has a market capitalization of $1.40 billion, a PE ratio of 53.06, a price-to-earnings-growth ratio of 1.49 and a beta of 0.79. The business has a 50 day simple moving average of $24.48 and a 200-day simple moving average of $24.59. IMAX Co. has a 12 month low of $14.94 and a 12 month high of $27.77.
Wall Street Analysts Forecast Growth
Several equities analysts recently weighed in on IMAX shares. Wells Fargo & Company cut their price target on shares of IMAX from $32.00 to $30.00 and set an “overweight” rating on the stock in a report on Thursday, April 24th. Wedbush reissued an “outperform” rating and set a $32.00 target price on shares of IMAX in a report on Thursday, April 17th. Macquarie upped their price target on shares of IMAX from $30.00 to $32.00 and gave the company an “outperform” rating in a report on Friday, April 25th. Barrington Research reiterated an “outperform” rating and set a $32.00 price objective on shares of IMAX in a research note on Thursday, April 24th. Finally, JPMorgan Chase & Co. dropped their target price on IMAX from $27.00 to $26.00 and set a “neutral” rating on the stock in a report on Friday, April 11th. Two analysts have rated the stock with a hold rating, eight have given a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $30.56.
Read Our Latest Report on IMAX
About IMAX
IMAX Corporation, together with its subsidiaries, operates as a technology platform for entertainment and events worldwide. The company operates in two segments, Content Solutions and Technology Products and Services. The company offers IMAX DMR, a proprietary technology that digitally remasters films and other content into IMAX formats for distribution to the IMAX network; IMAX Enhanced that provides end-to-end technology across streaming content and entertainment devices at home; and SSIMWAVE, an AI-driven video quality solutions for media and entertainment companies.
Read More
- Five stocks we like better than IMAX
- High Flyers: 3 Natural Gas Stocks for March 2022
- Google Is Betting Big on Nuclear Reactors—Should You?
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Taiwan Semiconductor Has a New Reason to Rally on Chip Curbs
- Should You Invest in Penny Stocks?
- Why Nearly 20 Analysts Raised Meta Price Targets Post-Earnings
Want to see what other hedge funds are holding IMAX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for IMAX Co. (NYSE:IMAX – Free Report).
Receive News & Ratings for IMAX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMAX and related companies with MarketBeat.com's FREE daily email newsletter.